198 related articles for article (PubMed ID: 22102833)
21. The essential role of AMPA receptor GluR2 subunit RNA editing in the normal and diseased brain.
Wright A; Vissel B
Front Mol Neurosci; 2012; 5():34. PubMed ID: 22514516
[TBL] [Abstract][Full Text] [Related]
22. The abnormal processing of TDP-43 is not an upstream event of reduced ADAR2 activity in ALS motor neurons.
Yamashita T; Hideyama T; Teramoto S; Kwak S
Neurosci Res; 2012 Jun; 73(2):153-60. PubMed ID: 22414730
[TBL] [Abstract][Full Text] [Related]
23. [Calpain plays a crucial role in TDP-43 pathology].
Yamashita T; Kwak S
Rinsho Shinkeigaku; 2014; 54(12):1151-4. PubMed ID: 25672733
[TBL] [Abstract][Full Text] [Related]
24. Newly identified ADAR-mediated A-to-I editing positions as a tool for ALS research.
Kwak S; Nishimoto Y; Yamashita T
RNA Biol; 2008; 5(4):193-7. PubMed ID: 18971634
[TBL] [Abstract][Full Text] [Related]
25. RNA Editing: A New Therapeutic Target in Amyotrophic Lateral Sclerosis and Other Neurological Diseases.
Hosaka T; Tsuji H; Kwak S
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681616
[TBL] [Abstract][Full Text] [Related]
26. Zebrafish Adar2 Edits the Q/R site of AMPA receptor Subunit gria2α transcript to ensure normal development of nervous system and cranial neural crest cells.
Li IC; Chen YC; Wang YY; Tzeng BW; Ou CW; Lau YY; Wu KM; Chan TM; Lin WH; Hwang SP; Chow WY
PLoS One; 2014; 9(5):e97133. PubMed ID: 24818983
[TBL] [Abstract][Full Text] [Related]
27. TDP-43 pathology in sporadic ALS occurs in motor neurons lacking the RNA editing enzyme ADAR2.
Aizawa H; Sawada J; Hideyama T; Yamashita T; Katayama T; Hasebe N; Kimura T; Yahara O; Kwak S
Acta Neuropathol; 2010 Jul; 120(1):75-84. PubMed ID: 20372915
[TBL] [Abstract][Full Text] [Related]
28. Testing of the therapeutic efficacy and safety of AMPA receptor RNA aptamers in an ALS mouse model.
Akamatsu M; Yamashita T; Teramoto S; Huang Z; Lynch J; Toda T; Niu L; Kwak S
Life Sci Alliance; 2022 Apr; 5(4):. PubMed ID: 35022247
[TBL] [Abstract][Full Text] [Related]
29. A new strategy to increase RNA editing at the Q/R site of GluA2 AMPA receptor subunits by targeting alternative splicing patterns of ADAR2.
Chaytow H; Sethw Hassan I; Akbar S; Popplewell L; Dickson G; Chen PE
J Neurosci Methods; 2021 Dec; 364():109357. PubMed ID: 34536489
[TBL] [Abstract][Full Text] [Related]
30. Down-regulation of the RNA editing enzyme ADAR2 contributes to RGC death in a mouse model of glaucoma.
Wang AL; Carroll RC; Nawy S
PLoS One; 2014; 9(3):e91288. PubMed ID: 24608178
[TBL] [Abstract][Full Text] [Related]
31. A new mouse line with reduced GluA2 Q/R site RNA editing exhibits loss of dendritic spines, hippocampal CA1-neuron loss, learning and memory impairments and NMDA receptor-independent seizure vulnerability.
Konen LM; Wright AL; Royle GA; Morris GP; Lau BK; Seow PW; Zinn R; Milham LT; Vaughan CW; Vissel B
Mol Brain; 2020 Feb; 13(1):27. PubMed ID: 32102661
[TBL] [Abstract][Full Text] [Related]
32. GluA2 is rapidly edited at the Q/R site during neural differentiation in vitro.
Pachernegg S; Münster Y; Muth-Köhne E; Fuhrmann G; Hollmann M
Front Cell Neurosci; 2015; 9():69. PubMed ID: 25798088
[TBL] [Abstract][Full Text] [Related]
33. Calpain-dependent disruption of nucleo-cytoplasmic transport in ALS motor neurons.
Yamashita T; Aizawa H; Teramoto S; Akamatsu M; Kwak S
Sci Rep; 2017 Jan; 7():39994. PubMed ID: 28045133
[TBL] [Abstract][Full Text] [Related]
34. Risperidone impedes glutamate excitotoxicity in a valproic acid rat model of autism: Role of ADAR2 in AMPA GluA2 RNA editing.
Habib MZ; Elnahas EM; Aboul-Ela YM; Ebeid MA; Tarek M; Sadek DR; Negm EA; Abdelhakam DA; Aboul-Fotouh S
Eur J Pharmacol; 2023 Sep; 955():175916. PubMed ID: 37460052
[TBL] [Abstract][Full Text] [Related]
35. Dysregulation of AMPA receptor subunit expression in sporadic ALS post-mortem brain.
Gregory JM; Livesey MR; McDade K; Selvaraj BT; Barton SK; Chandran S; Smith C
J Pathol; 2020 Jan; 250(1):67-78. PubMed ID: 31579943
[TBL] [Abstract][Full Text] [Related]
36. Effects of antidepressants on GluR2 Q/R site-RNA editing in modified HeLa cell line.
Sawada J; Yamashita T; Aizawa H; Aburakawa Y; Hasebe N; Kwak S
Neurosci Res; 2009 Jul; 64(3):251-8. PubMed ID: 19447293
[TBL] [Abstract][Full Text] [Related]
37. Requirement of the RNA-editing enzyme ADAR2 for normal physiology in mice.
Horsch M; Seeburg PH; Adler T; Aguilar-Pimentel JA; Becker L; Calzada-Wack J; Garrett L; Götz A; Hans W; Higuchi M; Hölter SM; Naton B; Prehn C; Puk O; Rácz I; Rathkolb B; Rozman J; Schrewe A; Adamski J; Busch DH; Esposito I; Graw J; Ivandic B; Klingenspor M; Klopstock T; Mempel M; Ollert M; Schulz H; Wolf E; Wurst W; Zimmer A; Gailus-Durner V; Fuchs H; de Angelis MH; Beckers J
J Biol Chem; 2011 May; 286(21):18614-22. PubMed ID: 21467037
[TBL] [Abstract][Full Text] [Related]
38. ADAR2-mediated Q/R editing of GluK2 regulates kainate receptor upscaling in response to suppression of synaptic activity.
Gurung S; Evans AJ; Wilkinson KA; Henley JM
J Cell Sci; 2018 Dec; 131(24):. PubMed ID: 30559217
[TBL] [Abstract][Full Text] [Related]
39. The Q/R editing site of AMPA receptor GluA2 subunit acts as an epigenetic switch regulating dendritic spines, neurodegeneration and cognitive deficits in Alzheimer's disease.
Wright AL; Konen LM; Mockett BG; Morris GP; Singh A; Burbano LE; Milham L; Hoang M; Zinn R; Chesworth R; Tan RP; Royle GA; Clark I; Petrou S; Abraham WC; Vissel B
Mol Neurodegener; 2023 Sep; 18(1):65. PubMed ID: 37759260
[TBL] [Abstract][Full Text] [Related]
40. A role for calpain-dependent cleavage of TDP-43 in amyotrophic lateral sclerosis pathology.
Yamashita T; Hideyama T; Hachiga K; Teramoto S; Takano J; Iwata N; Saido TC; Kwak S
Nat Commun; 2012; 3():1307. PubMed ID: 23250437
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
